|
PDCD6IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.335990E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.563200E-03 |
| Normal-vs-Stage2 |
8.981900E-03 |
| Normal-vs-Stage3 |
7.579200E-04 |
| Normal-vs-Stage4 |
5.596000E-04 |
| Stage1-vs-Stage2 |
5.894000E-01 |
| Stage1-vs-Stage3 |
2.263800E-01 |
| Stage1-vs-Stage4 |
2.127200E-01 |
| Stage2-vs-Stage3 |
7.483200E-01 |
| Stage2-vs-Stage4 |
7.119000E-01 |
| Stage3-vs-Stage4 |
9.431200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.364300E-04 |
| Normal-vs-AfricanAmerican |
1.743810E-01 |
| Normal-vs-Asian |
2.125700E-02 |
| Caucasian-vs-AfricanAmerican |
4.068000E-01 |
| Caucasian-vs-Asian |
6.721800E-01 |
| AfricanAmerican-vs-Asian |
6.540400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.015800E-04 |
| Normal-vs-Female |
3.658400E-03 |
| Male-vs-Female |
3.570000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.142400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.008300E-04 |
| Normal-vs-Age(61-80Yrs) |
8.444500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.663900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.786380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.075600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.736600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.910000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.552800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.875600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.355600E-01 |
| Classical-VS-Follicular |
2.398700E-03 |
| Classical-VS-Other |
3.082400E-01 |
| Classical-VS-Normal |
2.462400E-02 |
| Tall-VS-Follicular |
2.887000E-01 |
| Tall-VS-Other |
5.296000E-01 |
| Tall-VS-Normal |
2.286200E-02 |
| Follicular-VS-Other |
9.868200E-01 |
| Follicular-VS-Normal |
1.563170E-04 |
| Other-VS-Normal |
5.815900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.991700E-04 |
| Normal-vs-N1 |
1.164450E-03 |
| N0-vs-N1 |
9.199800E-01 |
|
|
